Mn Services Vermogensbeheer B.V. grew its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 61.3% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 170,525 shares of the financial services provider's stock after purchasing an additional 64,815 shares during the quarter. Mn Services Vermogensbeheer B.V.'s holdings in CME Group were worth $44,674,000 at the end of the most recent reporting period.
Several other large investors have also recently modified their holdings of CME. BlackRock Inc. bought a new stake in shares of CME Group in the second quarter valued at approximately $6,749,965,000. Bank of New York Mellon Corp bought a new position in CME Group in the 2nd quarter worth approximately $867,313,000. Alphabet Inc. bought a new position in CME Group in the 2nd quarter worth approximately $769,376,000. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in CME Group in the 2nd quarter valued at approximately $629,771,000. Finally, Bank of America Corp DE purchased a new position in CME Group in the 2nd quarter valued at approximately $622,679,000. Hedge funds and other institutional investors own 87.75% of the company's stock.
CME Group Stock Performance
NASDAQ:CME opened at $276.44 on Friday. The company has a market capitalization of $99.40 billion, a price-to-earnings ratio of 23.45, a PEG ratio of 3.54 and a beta of 0.24. The business has a 50 day moving average of $271.81 and a 200 day moving average of $271.19. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 1-year low of $218.31 and a 1-year high of $329.16.
CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, beating analysts' consensus estimates of $2.91 by $0.08. The business had revenue of $1.71 billion for the quarter, compared to analysts' expectations of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The business's quarterly revenue was up .8% on a year-over-year basis. During the same period last year, the business earned $2.96 earnings per share. On average, sell-side analysts predict that CME Group Inc. will post 12.28 earnings per share for the current fiscal year.
CME Group Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, September 25th. Investors of record on Wednesday, September 9th were issued a dividend of $1.30 per share. The ex-dividend date of this dividend was Wednesday, September 9th. This represents a $5.20 annualized dividend and a dividend yield of 1.9%. CME Group's dividend payout ratio (DPR) is currently 44.11%.
Analyst Ratings Changes
A number of equities analysts have recently commented on CME shares. Barclays raised their price target on CME Group from $270.00 to $281.00 and gave the stock an "equal weight" rating in a report on Wednesday. Bank of America boosted their price objective on CME Group from $226.00 to $230.00 and gave the company an "underperform" rating in a research note on Thursday, July 23rd. Raymond James Financial reissued an "outperform" rating and set a $320.00 price objective on shares of CME Group in a report on Thursday, July 2nd. Keefe, Bruyette & Woods upgraded CME Group from a "market perform" rating to an "outperform" rating and set a $305.00 target price for the company in a research note on Thursday, June 18th. Finally, JPMorgan Chase & Co. lifted their target price on CME Group from $249.00 to $250.00 and gave the company an "underweight" rating in a report on Thursday, July 23rd. Eight research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have given a Sell rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $291.62.
Read Our Latest Stock Analysis on CME Group
Insider Activity at CME Group
In other CME Group news, CEO Terrence A. Duffy sold 15,000 shares of the company's stock in a transaction dated Thursday, September 10th. The shares were sold at an average price of $274.44, for a total transaction of $4,116,600.00. Following the completion of the sale, the chief executive officer directly owned 40,630 shares in the company, valued at $11,150,497.20. This represents a 26.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Elizabeth A. Cook sold 500 shares of CME Group stock in a transaction dated Monday, September 14th. The stock was sold at an average price of $280.11, for a total value of $140,055.00. Following the completion of the transaction, the director owned 17,916 shares in the company, valued at approximately $5,018,450.76. This represents a 2.72% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is owned by insiders.
CME Group Profile
(
Free Report)
CME Group Inc operates global derivatives marketplaces that enable customers to manage risk and trade futures and options contracts. Its exchanges offer products linked to interest rates, equity indexes, foreign currencies, agricultural commodities, energy, metals and other asset classes.
The company also provides central counterparty clearing, settlement and related risk-management services for transactions conducted on its markets. In addition, CME Group offers market data, benchmark products and technology services that support trading, analysis and connectivity for financial institutions, businesses, professional traders and other market participants.
CME Group's history includes the Chicago Board of Trade, founded in 1848, and the Chicago Mercantile Exchange, established in 1898.
Featured Articles
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.